⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 21, 2012Pharmacogenetics and GenomicsOpen Access

Metformin pathways

View Full Paper

Ask AI

Bookmark

Share

Abstract

Gong, Li; Goswami, Srijib; Giacomini, Kathleen M.; Altman, Russ B.; Klein, Teri E. Author Information

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gong et al. (2012) studied this question.

synapsesocial.com/papers/6a76532e889e205583b1bf92 https://doi.org/10.1097/fpc.0b013e3283559b22

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Mechanism by which metformin reduces glucose production in type 2 diabetes.Original Research · 2000 · 1,059 citations
2A Common 5′-UTR Variant in MATE2-K Is Associated With Poor Response to MetforminRetrospective Study · 2011 · 157 citations
3Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver†Original Research · 2009 · 389 citations
4Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin PharmacokineticsOriginal Research · 2007 · 476 citations
5The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cellsOriginal Research · 2009 · 251 citations